BPC-157
peptideA lab-made peptide popular for injury recovery. Mostly animal data, and not an approved drug.
Guide
No lawful route exists for personal use. BPC-157 is not FDA-approved for any human use, and as of September 2026 it is not on the list of substances US pharmacies may compound from. An FDA advisory committee voted 8 to 6 in July 2026 to recommend adding it, but that vote is not binding and nothing is final.

No. BPC-157 is not approved for any use in people. FDA’s July 2026 briefing document found no studies giving BPC-157 to humans by injection, by mouth or by nose, and no information on how it behaves in the human body. FDA briefing, BPC-157

A 2025 systematic review in orthopaedic sports medicine found 36 BPC-157 studies, 35 of them preclinical, and no clinical safety data. HSS J 2025
Not today. A 503A pharmacy may compound from a bulk ingredient only if it meets federal criteria, such as appearing on FDA’s 503A bulks list, and FDA also tolerates Category 1 substances under an interim policy. BPC-157 qualifies under neither as of September 2026. The July 2026 advisory vote could change that, but only after FDA decides and completes rulemaking. 21 U.S.C. 353a

BPC-157 sits on FDA’s Category 2 list of bulk substances that may present significant safety risks. Orrick
FDA removes BPC-157 and 11 other peptides from Category 2 and schedules advisory committee review. Orrick
FDA’s Pharmacy Compounding Advisory Committee meets on peptides. FDA
The committee votes 8 to 6 to recommend adding BPC-157 to the 503A bulks list for ulcerative colitis, after FDA staff recommended against it. McDermott Will & Schulte
FDA decides whether to follow the vote and, if so, completes rulemaking. Until then there is no lawful compounding route. McDermott Will & Schulte
Not when it is marketed for people. FDA judges a product by how it is marketed, not by its disclaimer, and has sent warning letters to BPC-157 sellers whose sites promoted human use while labeling products “for research use only” and “not for human or veterinary use.” FDA warning letter

FDA sent a similar warning letter to another peptide seller in December 2024. FDA warning letter
FDA’s reviewers also found BPC-157 is not well characterized, testing for impurities and contamination was lacking, and it may pose a significant risk of immune reactions. FDA briefing, BPC-157
Yes. BPC-157 is prohibited at all times under the World Anti-Doping Agency’s 2026 list of non-approved substances. USADA says there are no human clinical trials establishing its efficacy and that it is unknown whether it is safe in any amount. USADA
An FDA decision to add BPC-157 to the 503A bulks list, followed by final rulemaking, would let licensed pharmacies compound it on an individual prescription. That would still not make it an FDA-approved drug, and it would not make “research” products lawful for people. McDermott Will & Schulte
See every compound in fitness, strength & recovery with its US status, evidence and risks. Only a licensed clinician who knows your history can decide what fits.
BPC-157 is not FDA-approved and cannot be lawfully compounded as of September 2026, so there is no lawful way to obtain it for human use. Selling it for human use has drawn FDA warning letters. It is also prohibited in sport under the WADA list.
Not lawfully today. There is no FDA-approved BPC-157 product, and it is not on the list of ingredients pharmacies may compound from, so a licensed clinician has nothing lawful to prescribe. That could change only if FDA adds it to the 503A bulks list through rulemaking.
No. In July 2026 an FDA advisory committee voted 8 to 6 to recommend adding BPC-157 to the compounding bulks list for ulcerative colitis. That is advice to FDA, not an approval, and FDA has to decide and complete rulemaking before anything changes.
Its safety in people is unknown. FDA found no studies giving it to humans by the routes it is marketed for, flagged a possible risk of immune reactions, and products sold online are not made to drug standards, so identity, purity and sterility are unverified.
Last reviewed September 23, 2026. Every source above was checked on or before that date. Educational information only, not medical advice; it does not replace a conversation with a licensed clinician. DiscoverMedica does not employ clinicians.